Vivani Medical unveils preclinical data on NPM-115, a twice-yearly exenatide subdermal implant for weight loss. Achieving a 20% reduction in high-fat diet-induced obese mice, comparable to Novo Nordisk's Ozempic/Wegovy.
Little-known emerging biopharmaceutical company Vivani Medical (NASDAQ:VANI) saw its market value increase dramatically on Wednesday. Catapulting sentiment…
Shares of Vivani Medical, Inc. (NASDAQ:VANI – Get Free Report) traded up 1% on Tuesday . The stock traded as high as $1.04 and last traded at $1.03. 12,489 shares traded hands during trading, a decline of 58% from the average session volume of 29,644 shares. The stock had previously closed at $1.02. Vivani Medical […]
The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Insider Buying: Vivani Medical, Inc (NASDAQ:VANI) Director Buys 13,067 Shares of Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.